Monaco Asset Management Sam Bluebird Bio, Inc. Transaction History

Monaco Asset Management Sam

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$1.32 - $4.83 $198,000 - $724,500	150,000 New	150,000 $206,000
Q4 2022 Jan 31, 2023	SELL	$5.77 - $8.49 $173,100 - $254,700	-30,000 Reduced 37.5%	50,000 $346,000
Q3 2022 Oct 31, 2022	SELL	$3.75 - $7.39 $848,032 - $1.67 Million	-226,142 Reduced 73.87%	80,000 $506,000
Q2 2022 Aug 01, 2022	BUY	$2.94 - $5.23 $900,057 - $1.6 Million	306,142 New	306,142 $1.27 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $23.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

Stay updated on Monaco Asset Management Sam with notifications on news.